LOS ANGELES--(BUSINESS WIRE)--Grant Life Sciences (‘Grant’) Inc. (OTC BB: GLIF) announced today that it has hired Mr. Kim Liao as director of Asian business development, effective immediately. “We are extremely pleased to have such an accomplished industry executive as Kim Liao join Grant Life Sciences, particularly in light of his significant ‘hands on’ experience in the markets of Taiwan, China and Singapore,” said Hun-Chi Lin, Ph.D., Grant’s President and Chief Scientist. “Certainly, Kim will play a key role in executing Grant’s new corporate strategy: (1) acquire new products and technologies via in-licensing activities; (2) out-license products for further development and sales; and (3) drive sales through our established marketing channels. Kim will oversee development of Grant’s expansion into Asia, including the structuring of clinical trials for our HPV-DNA tests at United Clinical Lab (the largest reference lab in Taiwan} and National Taiwan University’s Medical Center. In short, Kim will be spearheading the commercialization of Grant’s products from clinical acceptance to sales in new, key Asian markets.”
